Voices
Myeloma Paper of the Day, July 5th, Suggested by Robert Orlowski

Myeloma Paper of the Day, July 5th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Results from CASSIOPEIA trial suggest pts w/ cyclin D1 overexpression and t(11;14) exhibit slower response rates after induction and high-dose therapy in setting of triplet or quads but long-term prognosis remains favorable.”

Title: Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial

Authors: Aurore Perrot, Cyrille Touzeau, Stéphane Minvielle, Cyrille Hulin, Denis Caillot, Salomon Manier, Xavier Leleu, Cécile Sonntag, Karim Belhadj, Bertrand Arnulf, Thomas Chalopin, Jean-Richard Eveillard, Martine Escoffre-Barbe, Lionel Karlin, Laure Vincent, Margaret Macro, Hervé Avet-Loiseau, Soraya Wuilleme, Ariane Boumendil, Jill Corre, Philippe Moreau

You can read the Full Article on Blood Cancer Journal. 

Myeloma Paper of the Day, July 5th, Suggested by Robert Orlowski

You can find other articles featuring Robert Orlowski on OncoDaily.

Ariane Boumendil Aurore Perrot Bertrand Arnulf cancer CASSIOPEIA trial Cécile Sonntag Cyrille Hulin Cyrille Touzeau Denis Caillot Hervé Avet-Loiseau Jean-Richard Eveillard Jill Corre Karim Belhadj Laure Vincent Lionel Karlin Margaret Macro Martine Escoffre-Barbe Myeloma Paper of the Day OncoDaily Oncology Philippe Moreau Robert Orlowski Salomon Manier Soraya Wuillème Stéphane Minvielle Thomas Chalopin Xavier Leleu